McKesson bolsters support of pharmacy ownership
McKesson Corp.’s RxOwnership team is sponsoring educational programs for current and future pharmacists considering pharmacy ownership at the 2017 NCPA Annual Conference.
Supplier News
Catalina names global chief retail officer
Tom Corley has joined Catalina as global chief retail officer and president of U.S. retail. The shopper intelligence and personalized digital media firm said Monday that, in the role, Corley will lead Catalina’s U.S.
Emerson Group promotes Ed Morgan to president
The Emerson Group has named Ed Morgan as president. Prior to his promotion, Morgan was serving the company as vice president and partner. He joined Emerson in 2005 as business manager, a role that allowed him to contribute to the company’s Bentonville, Ark.
Hibiclens clears up hand washing misperceptions
Consumers aren’t quite clear about effective protection against germs, bacteria and viruses, according to a survey commissioned by Mölnlycke Health Care, the maker of Hibiclens antiseptic skin cleanser.
KISS Gold Edition hair tools roll out to Walmart, Kroger
KISS Products Inc. is expanding retail distribution of its KISS Gold Edition hair appliances and accessories to Walmart and Kroger. KISS said Wednesday that the rollout to the two mass chains builds on KISS Gold Edition’s launch in July exclusively at Amazon.com.
Key Brands appoints sales and marketing director
Vanessa Haynes has been named director of sales and marketing at hair care and skin care manufacturer Key Brands International Ltd.
Coty unveils new brand vision for CoverGirl
Coty Inc. is redefining the CoverGirl brand in an effort that the company describes as “the biggest reinvention in CoverGirl’s 60-year history.” The brand vision for CoverGirl, acquired just over a year ago from Procter & Gamble Co., will now be under the mantra “I Am What I Make Up.” Coty said
Mylan releases Concerta generic
Mylan N.V. has launched methylphenidate hydrochloride extended-release tablets, a medication for attention deficit hyperactivity disorder (ADHD), in the United States. Mylan said its product, a generic version of Concerta tablets from Janssen Pharmaceuticals Inc.
CEO succession in store at Hershey in new year
The new year will bring new leadership to chocolate, candy and snack giant The Hershey Co. Plans call for Michele Buck, executive vice president and chief operating officer, to take the reins as president chief executive officer on March 1, succeeding John Bilbrey.
Prestige Brands to acquire C.B. Fleet Co.
Prestige Brands Holdings Inc. plans to buy over-the-counter medicine and personal care manufacturer C.B. Fleet Co. from private equity firm Gryphon Investors for $825 million in cash.
Hydroxycut launches weight-loss app
Weight-control supplement brand Hydroxycut has rolled out a free weight-loss mobile app. Iovate Health Sciences International Inc.
Cardinal Health settles civil portion of 2012 diversion case
Cardinal Health Inc. has reached a nationwide settlement with the federal government that resolves the outstanding civil penalty portion of its 2012 administrative settlement with the Drug Enforcement Administration (DEA).
Endo makes changes to executive team
Endo International plc has announced executive changes in its U.S. branded drug and research-and-development units. Endo said Patrick Barry has been appointed as senior vice president of U.S.
Huggies first to offer buy-in-bulk for diaper banks
Early next year, Huggies plans to launch a program enabling diaper banks to buy bulk quantities of its diapers at competitive prices. The Kimberly-Clark baby care brand said Thursday that it will be the first global diaper brand to offer such a program.
Pantene signs Priyanka Chopra as brand ambassador
Actress and philanthropist Priyanka Chopra has been named as Pantene’s newest global brand ambassador.
Upsher-Smith sells AmLactin to Sandoz
Upsher-Smith Laboratories Inc. has entered an agreement to sell its AmLactin skin care brand to Sandoz Inc. Financial terms of the deal weren’t disclosed. Upsher-Smith said the move is part of its strategy of focusing on generic drugs and novel therapies.